STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $33.2K priced
What the filings say about ASRV
Insiders, 180 days
-$27.5K net sold
1 buyer · 1 seller · 0% of sales under a 10b5-1 plan
Ameriserv Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, AMERISERV FINANCIAL INC /PA/ insiders sold a net $27.5K of stock across 109 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Aug 31, 2026.
The trade is 289.0% of the 2,250 shares held after it.
No other insider sold within 30 days.
Insider activity: EVP - ASRV Wealth & Cap. Mgmt. FINUI DAVID A sold about $31.0K of ASRV on Sep 4, 2026, the largest insider sale at the company since 2021.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 155.5% of the 2,250 shares held after it.
No other insider sold within 30 days.
Insider activity: EVP - ASRV Wealth & Cap. Mgmt. FINUI DAVID A sold about $17.9K of ASRV on Aug 31, 2026, the largest insider sale at the company since 2021.
30 earlier Form 4 trades (code P or S) here by this insider (30 buys), the last on Sep 12, 2025.
+5.1% median (+1.4% mean) 90-day return after 28 previous buys.
The trade is 1.8% of the 169,379 shares held after it.
No other insider bought within 30 days.
Insider activity: President & CEO ASRV & Bank STOPKO JEFFREY A bought about $11.6K of ASRV on May 5, 2026, the largest insider purchase at the company since 2022.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$15.0M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ASRV
FY Dec 2025
$14.6M
FY Dec 2024
$15.6M
FY Dec 2023
$14.5M
FY Dec 2022
$14.7M
FY Dec 2021
$15.0M
Jun 2026
$3.9M
Mar 2026
$3.6M
Dec 2025
$3.9M
Sep 2025
$3.7M
Jun 2025
$3.6M
Mar 2025
$3.5M
Dec 2024
$3.8M
Sep 2024
$3.9M
At each fiscal year end
Single quarter
Net margin, TTM
+56.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ASRV
FY Dec 2025
+38.3%
FY Dec 2024
+23.1%
FY Dec 2023
-23.1%
FY Dec 2022
+50.5%
FY Dec 2021
+47.3%
Jun 2026
+70.7%
Mar 2026
+49.7%
Dec 2025
+36.9%
Sep 2025
+69.5%
Jun 2025
-7.8%
Mar 2025
+55.0%
Dec 2024
+23.3%
Sep 2024
+30.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
$180.0K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ASRV
FY Dec 2025
$1.5M
FY Dec 2024
$976.0K
FY Dec 2023
$4.9M
FY Dec 2022
$3.1M
FY Dec 2021
$8.7M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
$3.6M
Sep 2024
-$1.0M
At each fiscal year end
Single quarter
Debt to equity
0.02x
current debt only, 2025-06-30 (12 months older than the period end); equity 2026-06-30
Debt to equity ASRV
FY Dec 2025
0.02x
FY Dec 2024
0.14x
FY Dec 2023
0.40x
FY Dec 2022
0.83x
FY Dec 2021
0.00x
Jun 2026
0.02x
Mar 2026
0.02x
Dec 2025
0.02x
Sep 2025
0.02x
Jun 2025
0.02x
Mar 2025
0.09x
Dec 2024
0.14x
Sep 2024
0.11x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.70x
TTM operating cash flow over current debt only, 2025-06-30 (12 months older than the period end)
Cash flow to debt ASRV
FY Dec 2025
1.19x
FY Dec 2024
0.18x
FY Dec 2023
0.15x
FY Dec 2022
0.06x
FY Dec 2021
n/a
Jun 2026
0.70x
Mar 2026
1.10x
Dec 2025
1.19x
Sep 2025
1.98x
Jun 2025
1.37x
Mar 2025
0.52x
Dec 2024
0.18x
Sep 2024
0.04x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ASRV
FY Dec 2025
+5.0%
FY Dec 2024
+3.4%
FY Dec 2023
-3.2%
FY Dec 2022
+6.7%
FY Dec 2021
+6.4%
Jun 2026
+7.3%
Mar 2026
+4.8%
Dec 2025
+5.0%
Sep 2025
+4.5%
Jun 2025
+3.4%
Mar 2025
+3.4%
Dec 2024
+3.4%
Sep 2024
-2.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ASRV
FY Dec 2025
+0.4%
FY Dec 2024
+0.3%
FY Dec 2023
-0.2%
FY Dec 2022
+0.6%
FY Dec 2021
+0.5%
Jun 2026
+0.6%
Mar 2026
+0.4%
Dec 2025
+0.4%
Sep 2025
+0.4%
Jun 2025
+0.3%
Mar 2025
+0.3%
Dec 2024
+0.3%
Sep 2024
-0.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ASRV
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ASRV
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
9.18x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ASRV
FY Dec 2025
9.38x
FY Dec 2024
12.76x
FY Dec 2023
n/a
FY Dec 2022
8.95x
FY Dec 2021
9.41x
Jun 2026
7.61x
Mar 2026
10.97x
Dec 2025
9.38x
Sep 2025
9.67x
Jun 2025
13.82x
Mar 2025
11.05x
Dec 2024
12.76x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$21.9M
market value at close 2026-10-27 on 2026-08-10 shares, plus current debt only, 2025-06-30 (12 months older than the period end), minus cash 2021-06-30
Enterprise value ASRV
FY Dec 2025
-$4.8M
FY Dec 2024
-$1.3M
FY Dec 2023
$36.3M
FY Dec 2022
$95.8M
FY Dec 2021
$5.7M
Jun 2026
$8.3M
Mar 2026
$3.9M
Dec 2025
-$4.8M
Sep 2025
-$9.6M
Jun 2025
-$7.3M
Mar 2025
-$9.7M
Dec 2024
-$1.3M
Sep 2024
-$5.4M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+0.2%
TTM free cash flow over market value at close 2026-10-27
FCF yield ASRV
FY Dec 2025
+2.8%
FY Dec 2024
+2.2%
FY Dec 2023
+8.8%
FY Dec 2022
+4.6%
FY Dec 2021
+13.2%
Jun 2026
+0.3%
Mar 2026
+2.0%
Dec 2025
+2.8%
Sep 2025
+7.5%
Jun 2025
+3.9%
Mar 2025
+9.3%
Dec 2024
+2.2%
Sep 2024
-4.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.07x
P/E over trailing EPS growth of 132%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing ASRV
FY Dec 2025
0.15x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
1.22x
FY Dec 2021
0.16x
Jun 2026
0.06x
Mar 2026
0.22x
Dec 2025
0.15x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ASRV ranks highest on financial health (74th percentile) and risk and compliance (73rd), and lowest on growth (9th), among Banks peers.
Profitability
22
Inputs
Return on equity+7.3% · 26 pct, sector of 327
Return on assets+0.6% · 19 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
74
Inputs
Debt to equity0.02x · 82 pct, sector of 229
Cash flow to debt0.70x · 66 pct, sector of 198
Growth
9
Inputs
Revenue growth, YoY-6.3% · 9 pct, sector of 151
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
56
Inputs
Net Form 4 buying (codes P and S), 180d-$27K · 65 pct, sector of 273
Insider buyers, 180d1 · 47 pct, sector of 273
Risk and compliance
73
Inputs
Short interest, % of float+1.2% · 73 pct, sector of 374
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Institutional and government, US patents
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ASRV filings, in plain words
Are Ameriserv Financial insiders buying or selling ASRV?
In the 180 days to 2026-10-28, Ameriserv Financial insiders were net sellers, a net $27.5K: $21.4K of purchases and $48.9K of sales reported on Form 4, by 1 buyer and 1 seller.
Read the full summary
In the 180 days to 2026-10-28, Ameriserv Financial insiders were net sellers of ASRV, a net $27.5K across purchases and sales reported on Form 4 by 1 buyer and 1 seller. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.